Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
XFuel produces sustainable and net-zero road, marine and aviation drop-in fuels
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.
Nourished provides a customized nutrition product that uses patented 3D printing technology to create bespoke gummy vitamins on demand.
Maeving is a new ear of beautiful, classically-styled electric motorcycles.
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
Globally-unique platform technology for the development of single-molecule crop biostimulants.
Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Quantum technology spin-out from the University of Oxford
Linear Diagnostics Limited is a diagnostics company based on a novel technology
Q5D provides the robotic tools, software and services needed to automate the manufacture of wiring harnesses
Zentraxa has specialise in the design, production and testing of complex novel peptides.
Inicio AI is a SaaS platform that builds the conversational AI driven tool that helps in income and expenditure assessment.
When in Rome plays a leading role in decarbonising the wine industry, selling Italian craft wines in eco-friendly alt packaging
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Presymptom Health is a pioneering Medtech company that creates innovative tests to diagnose illnesses earlier to help save lives.
4.01 is a company that specializes in eliminating CO2 from the atmosphere by mineralizing it in peridotite.
Vitarka Therapeutics develops medical technology and solutions for various types of cancer.
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Smart Green Shipping develops technical, commercially viable, digitally enabled wind-powered solutions.
Future Planet Capital has invested in 174 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Future Planet Capital's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Automotive. The firm invests across 42 different industry categories.
Among tracked funding rounds, Alloyed received $48.0M in a Series B round. Future Planet Capital's total known invested capital is $1.1B.
Future Planet Capital's average investment size is $7.4M across its portfolio of 174 companies.
Recent Future Planet Capital portfolio additions include XFuel, Nuclera, Ultromics, Nourished, Maeving. These companies were founded in 2020 or later.